Warnell P
Axone. 1996 Jun;17(4):86-92.
Despite advances in the diagnosis and surgical treatment of aneurysmal subarachnoid hemorrhage (SAH), the morbidity and mortality rates remain disturbingly high. In those patients that survive the initial event, deaths due to re-bleeding have been reduced as a result of a trend to earlier surgical repair of the aneurysm. Unfortunately, a large percentage of patients go on to die or become permanently disabled from cerebral infarction as a consequence of vasospasm. The exact mechanisms that contribute to the development of cerebral vasospasm in these patients continue to elude researchers. The pathological processes implicated in the vasospasm phenomenon will be described. Even though no single pharmacological agent or treatment protocol has been identified that prevents or reverses this deadly complication, a number of promising intervention strategies are being employed in the critical care setting. These will be explored in light of the most current research findings. Clearly, early detection and prompt treatment are vital if the outcomes for persons suffering aneurysmal SAH are to improve. A sound knowledge base, well-developed assessment and clinical reasoning skills, and a deeper understanding of the pathological processes and treatment objectives will assist the neuroscience practitioner to more ably care for these most challenging patients.
尽管在动脉瘤性蛛网膜下腔出血(SAH)的诊断和外科治疗方面取得了进展,但其发病率和死亡率仍然高得令人不安。在那些从初始事件中存活下来的患者中,由于动脉瘤早期手术修复的趋势,再出血导致的死亡有所减少。不幸的是,很大一部分患者因血管痉挛而死亡或永久性致残。导致这些患者发生脑血管痉挛的确切机制仍然困扰着研究人员。本文将描述与血管痉挛现象相关的病理过程。尽管尚未确定能预防或逆转这种致命并发症的单一药物或治疗方案,但在重症监护环境中正在采用一些有前景的干预策略。将根据最新研究结果对这些策略进行探讨。显然,如果要改善动脉瘤性SAH患者的预后,早期发现和及时治疗至关重要。扎实的知识库、完善的评估和临床推理技能,以及对病理过程和治疗目标的更深入理解,将有助于神经科学从业者更妥善地护理这些极具挑战性的患者。